<?xml version="1.0" encoding="UTF-8"?>
<p class="p">We previously found that Mediterranean EOs loaded-NLC were able to reduce the cytotoxicity of the pure EO on RAW 264.7 cells (murine macrophage cell line) [
 <xref rid="B15-pharmaceutics-11-00231" ref-type="bibr" class="xref">15</xref>]. Herein we found, interestingly, an increase in the ability of the EO in reducing the skin cell viability when it was encapsulated in the NLC structure (
 <xref rid="pharmaceutics-11-00231-t003" ref-type="table" class="xref">Table 3</xref>). This could be due to the presence of the surfactantsâ€“solid lipid membrane acting, at the nanoparticle surface, as a protective shell able to avoid the loss of the volatile compounds, thus increasing the bioavailability of EO to the biological systems [
 <xref rid="B39-pharmaceutics-11-00231" ref-type="bibr" class="xref">39</xref>].
</p>
